Headache and Nausea after Treatment with High‐Dose Subcutaneous versus Intravenous Immunoglobulin

Publisher： John Wiley & Sons Inc

E-ISSN： 1742-7843|117|6|409-412

ISSN： 1742-7835

Source： BASIC AND CLINICAL PHARMACOLOGY & TOXICOLOGY (ELECTRONIC), Vol.117, Iss.6, 2015-12, pp. : 409-412

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Stroke after High-Dose Intravenous Immunoglobulin

By  

Transfusion Medicine and Hemotherapy, Vol. 30, Iss. 4, 2003-09 ,pp. : 186-188

Karger

Access to resources Recommend Favorite

Successful Treatment of a Therapy‐Resistant Severely Pruritic Skin Eruption of Malignancy‐Associated Dermatomyositis with High‐Dose Intravenous Immunoglobulin

By  

THE JOURNAL OF DERMATOLOGY, Vol. 23, Iss. 5, 1996-05 ,pp. : 340-343

John Wiley & Sons Inc

Access to resources Recommend Favorite

Randomized Trial of Anti-D Immunoglobulin versus Low-Dose Intravenous Immunoglobulin in the Treatment of Childhood Chronic Idiopathic Thrombocytopenic Purpura

By  

Acta Haematologica, Vol. 115, Iss. 1-2, 2006-01 ,pp. : 46-52

Karger

Access to resources Recommend Favorite

Takotsubo Cardiomyopathy after Systemic Consolidation Therapy with High-Dose Intravenous Cytarabine in a Patient with Acute Myeloid Leukemia

By  

Oncology Research and Treatment, Vol. 37, Iss. 9, 2014-07 ,pp. : 487-490

Karger

Access to resources Recommend Favorite

Infections after T‐replete haploidentical transplantation and high‐dose cyclophosphamide as graft‐versus‐host disease prophylaxis

By  

TRANSPLANT INFECTIOUS DISEASE (ELECTRONIC), Vol. 17, Iss. 2, 2015-04 ,pp. : 242-249

John Wiley & Sons Inc

Access to resources Recommend Favorite